News

  • Major Regulatory Changes: Excipients and Packaging in China

    by Comments

    Stay Up-To-Date on New Industry Trends. FMDView is a periodic publication on drug development with keen interests in China. We publish short articles on regulatory, clinical management, drug safety and related subjects. The authors are mostly FMD colleagues who work on the front line of drug development. Sometimes we will have articles by leading investigators ...

    Read more
  • FMD K&L – Upcoming Conferences

    by Comments

    June 13, 2019 The DIA Annual Meeting is approaching quickly! We hope to see you at our booth, # 724, in San Diego, June 24-27. Use our Promo Codes for a discount: VIP19203 for $100 off registration, and HALL19203 for $150 off a day pass. FMD K&L is delighted to be attending PharmaSug 2019, June 16-19 in ...

    Read more
  • Predicine Partners with FMD to Accelerate Biomarker‐driven Clinical Trials and Regulatory Approvals in the U.S. and China

    by Comments

    FMD-Predicine press release. May 30, 2019 Predicine today announced a strategic partnership with FMD to help biopharma companies accelerate biomarker‐driven clinical trials and concurrent New Drug Application (NDA) submissions in the U.S. and China. The collaboration structure allows for global development of novel oncology therapies for biopharmaceutical companies, including global clinical trial support, regulatory support, and biomarker‐ driven drug development, and ...

    Read more
  • Leverage the Favorable Regulatory Reforms in China to Accelerate Global Drug Development Programs. Watch Recorded Webinar.

    by Comments

    FMD has successfully hosted a webinar titled “Leverage the Favorable Regulatory Reforms in China to Accelerate Global Drug Development Programs“. Dr. Dan Zhang, Executive Chairman of FMD, and Emil Fu, SVP International Integration of FMD, discussed the regulatory reform in China and the strategies biopharma companies can take to make your programs more efficient. In this ...

    Read more
  • FMD K&L , Chennai Floods – Rehabilitation Support Project in Chennai, India.

    by Comments

    On November 2016, the city of Chennai experienced massive floods which resulted in a tremendous loss of life and property. As part of flood relief efforts, FMD K&L supported RAINDROPSS, a social organization, for the successful execution of their Rehabilitation Support Project. The project involved reconstruction of SEERS homes which were damaged by the floods. ...

    Read more
  • FMD K&L Announces New Leadership Team

    by Comments

    FMD K&L Inc. (FMD K&L), a privately owned Contract Research Organization (CRO), is pleased to announce their new leadership team following a merger with iMEDGlobal Corporation (iMEDGlobal).  The new leadership team will work alongside the existing leadership to help define the strategy and company growth of its global operations.  Our newly promoted President of Global Biometrics, Tiepu Liu, ...

    Read more
  • FMD K&L Merged with iMEDGlobal

    by Comments

    Princeton, NJ – FMD K&L Inc. (FMD K&L) and iMEDGlobal Corporation (iMEDGlobal) are pleased to announce that they have entered into a merger agreement. FMD K&L is a privately owned Contract Research Organization (CRO) with headquarters in the USA and China. iMEDGlobal is a privately owned CRO with headquarters in the USA and with main ...

    Read more
  • FMD K&L Europe unit Yerevan Hosts Seminars on Clinical Research

    by Comments

    FMD K&L Europe unit in Yerevan, Armenia conducts workshops on the topic of “Experience and Potential of GCP clinical trials in Armenia” since May, 2016. This is the first step towards a new bright future of Armenia Bio-industry, which also attracts the attention of Armenian local media-news.am. The following is the article written in the website ...

    Read more
  • China-Based Contract Research Organization Selects Oracle Cloud to Optimize Clinical Trial Data Management

    by Comments

     Fountain Medical Development (FMD), a full-service Contract Research Organization (CRO) headquartered in Beijing, China, and its US affiliate, FMD K&L, have adopted Oracle’s cloud-based clinical data management solutions, to increase operational efficiencies and speed time to market. The solutions deliver increased productivity to the company’s drug development process, reduce overall costs, improve communications with its ...

    Read more
  • FMD K&L Expands Operations to the West Coast Region of the US

    by Comments

    FMD K&L, a privately owned Contract Research Organization (CRO) with headquarters in the US and China, recently expanded their operations to the West Coast region of the US to support growing client needs in North America.  “As our business continues to experience rapid growth this year, having a footprint where our industry is heavily penetrated ...

    Read more